永赢医药创新智选混合发起C(015916)
2026-01-29
1.6204
-1.0322%
| 报告期 |
基金净值 |
股票 |
国债及现金 |
可转债 |
企业债 |
金融债 |
其他债券 |
其他投资 |
贷方余额 |
| 2025-12-31 | 593,064.71 | 518,134.64 | 102,864.56 | 0.00 | 0.00 | 0.00 | 0.00 | 12,698.70 | 0.00 |
| 2025-09-30 | 782,858.58 | 710,540.73 | 120,106.14 | 0.00 | 0.00 | 0.00 | 0.00 | 7,696.09 | 0.00 |
| 2025-06-30 | 304,281.81 | 276,604.75 | 55,284.37 | 0.00 | 0.00 | 0.00 | 0.00 | 8,342.33 | 0.00 |
| 2025-03-31 | 72,178.43 | 66,165.42 | 14,626.44 | 0.00 | 0.00 | 0.00 | 0.00 | 9,979.07 | 0.00 |
| 2024-12-31 | 17,130.32 | 15,844.28 | 1,546.04 | 0.00 | 0.00 | 0.00 | 0.00 | 199.00 | 0.00 |
| 2024-09-30 | 25,004.83 | 23,580.15 | 2,245.35 | 0.00 | 0.00 | 0.00 | 0.00 | 793.14 | 0.00 |
| 2024-06-30 | 24,508.02 | 22,654.26 | 2,528.58 | 0.00 | 0.00 | 20.49 | 0.00 | 169.53 | 0.00 |
| 2024-03-31 | 24,493.09 | 22,891.57 | 2,270.81 | 0.00 | 0.00 | 0.00 | 0.00 | 377.81 | 0.00 |
| 2023-12-31 | 33,269.68 | 30,895.88 | 2,179.54 | 0.00 | 0.00 | 0.00 | 0.00 | 1,740.55 | 0.00 |
| 2023-09-30 | 19,850.03 | 18,769.84 | 1,665.97 | 0.00 | 0.00 | 0.00 | 0.00 | 618.94 | 0.00 |
| 2023-06-30 | 16,196.84 | 14,774.13 | 1,722.69 | 0.00 | 0.00 | 0.00 | 0.00 | 94.85 | 0.00 |
| 2023-03-31 | 5,531.74 | 5,184.74 | 495.96 | 0.00 | 0.00 | 0.00 | 0.00 | 98.39 | 0.00 |
| 2022-12-31 | 1,216.07 | 1,158.88 | 77.49 | 0.00 | 0.00 | 0.00 | 0.00 | 2.52 | 0.00 |
